Helicobacter Pylori Augments the PH-increasing Effect of Omeprazole in Patients with Duodenal Ulcer
Overview
Affiliations
Background & Aims: Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers. The aim of this study was to determine whether Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcers.
Methods: In 16 patients with duodenal ulcers, baseline intragastric acidity was measured before and 4-6 weeks after the cure of H. pylori infection. In 17 patients with duodenal ulcers, 24-hour pH metry was performed during treatment with 20 mg omeprazole once daily before as well as after eradication of H. pylori. Intragastric acidity was measured using a glass electrode placed 5 cm below the cardia. H. pylori infection was assessed by [13C] urea breath test, culture, histology, and rapid urease test.
Results: H. pylori eradication resulted in marked decrease of the pH-increasing effect of omeprazole (24-hour median gastric pH, 5.5 vs. 3.0; P<0.002) that was most pronounced during nighttime (median gastric pH, 6.4 vs. 2.1; P=0.001). On the other hand, baseline intragastric pH remained unchanged after eradication (median gastric pH, 1.0 vs. 1.1; P=0.5).
Conclusions: In patients with duodenal ulcers treated with omeprazole, intragastric pH depends significantly on the presence or absence of H. pylori, whereas baseline pH remained unchanged after H. pylori eradication.
Association Between Acid-Suppressive Agents' Use and Risk of Hepatocellular Carcinoma.
Lin H, Hsu H, Lin H, Uang Y, Ho Y, Wang L Dose Response. 2022; 18(2):1559325820907530.
PMID: 35185412 PMC: 8851131. DOI: 10.1177/1559325820907530.
Shu X, Zhu Z, Fu Y, Zhang Z, Wang J, Li X Front Med (Lausanne). 2021; 8:690995.
PMID: 34336894 PMC: 8317206. DOI: 10.3389/fmed.2021.690995.
Shimodaira Y, Onochi K, Watanabe K, Takahashi S, Fukuda S, Watanabe N Intest Res. 2020; 19(2):225-231.
PMID: 32806877 PMC: 8100376. DOI: 10.5217/ir.2020.00023.
And Duodenal Ulcer: Systematic Review Of Controversies In Causation.
Ahmed S, Belayneh Y Clin Exp Gastroenterol. 2019; 12:441-447.
PMID: 31819586 PMC: 6873956. DOI: 10.2147/CEG.S228203.
Mohn E, Kern H, Saltzman E, Mitmesser S, McKay D Pharmaceutics. 2018; 10(1).
PMID: 29558445 PMC: 5874849. DOI: 10.3390/pharmaceutics10010036.